BCRX logo

BioCryst Pharmaceuticals (BCRX) Total Expenses

Annual Total Expenses

$435.12 M
+$15.86 M+3.78%

December 31, 2023

Summary

Performance

1-Year Change

+3.78%

3-Year Change

+125.96%

5-Year Change

+278.78%

15-Year Change

+426.8%

BCRX Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.12%
BCRX annual total expenses is higher than 78.12% of companies in Healthcare sector

High & Low

All-time High

$435.12 M
BCRX annual total expenses is currently at an all-time high

3-Year Low

$334.89 M
BCRX annual total expenses is currently +29.93% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
BCRX next annual earnings announcement has not yet been scheduled

OtherBCRXexpensesmetrics:

Annual Interest Expense

$108.24 M
BCRX annual interest expense is $108.24 million

Annual Income Tax

$310.00 K
BCRX annual income tax is $310.00 thousand

Annual Operating Expenses

$430.46 M
BCRX annual total operating expenses is $430.46 million

Annual Cost Of Goods Sold

$4.66 M
BCRX annual cost of goods sold is $4.66 million

Quarterly Total Expenses

$109.39 M
+$8.82 M+8.77%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+27.83%

5-Year Change

+196.68%

BCRX Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.09%
BCRX quarterly total expenses is higher than 77.09% of companies in Healthcare sector

High & Low

All-time High

$136.07 M
BCRX quarterly total expenses is currently -19.61% below its historical high of $136.07 million

3-Year Low

$93.27 M
BCRX quarterly total expenses is currently +17.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
BCRX next earnings announcement has not yet been scheduled

OtherBCRXexpensesmetrics:

Quarterly Interest Expense

$24.83 M
BCRX quarterly interest expense is $24.83 million

Quarterly Income Tax

$586.00 K
BCRX quarterly income tax is $586.00 thousand

Quarterly Operating Expenses

$106.17 M
BCRX quarterly total operating expenses is $106.17 million

Quarterly Cost Of Goods Sold

$3.23 M
BCRX quarterly cost of goods sold is $3.23 million

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual Total Expenses

$435.12 M
BCRX annual total expenses is $435.12 million

Annual Cost Of Goods Sold

$4.66 M
BCRX annual cost of goods sold is $4.66 million

Annual Operating Expenses

$430.46 M
BCRX annual total operating expenses is $430.46 million

BCRX Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.8%0.0%
3 y3 years+126.0%+27.8%
5 y5 years+278.8%+196.7%

BCRX Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+29.9%-19.6%+17.3%
5 y5-yearat high+193.4%-19.6%+174.6%
alltimeall timeat high+5701.6%-19.6%+6737.1%

BioCryst Pharmaceuticals Total Expenses History

DateAnnualQuarterly
Sep 2024
-
$109.39 M(+8.8%)
Jun 2024
-
$100.57 M(-6.2%)
Mar 2024
-
$107.25 M(-21.2%)
Dec 2023
$435.12 M(+3.8%)
$136.07 M(+37.9%)
Sep 2023
-
$98.66 M(-4.4%)
Jun 2023
-
$103.19 M(+6.2%)
Mar 2023
-
$97.19 M(-22.8%)
Dec 2022
$419.26 M(+25.2%)
$125.86 M(+34.9%)
Sep 2022
-
$93.27 M(-7.0%)
Jun 2022
-
$100.25 M(+0.4%)
Mar 2022
-
$99.88 M(+0.5%)
Dec 2021
$334.89 M(+73.9%)
$99.33 M(+16.1%)
Sep 2021
-
$85.58 M(+7.6%)
Jun 2021
-
$79.54 M(+12.9%)
Mar 2021
-
$70.44 M(+24.8%)
Dec 2020
$192.57 M(+29.9%)
$56.42 M(+15.2%)
Sep 2020
-
$48.97 M(+18.3%)
Jun 2020
-
$41.38 M(-9.7%)
Mar 2020
-
$45.80 M(+15.0%)
Dec 2019
$148.29 M(+29.1%)
$39.83 M(+8.0%)
Sep 2019
-
$36.87 M(+1.4%)
Jun 2019
-
$36.37 M(+3.3%)
Mar 2019
-
$35.22 M(+25.8%)
Dec 2018
$114.87 M(+39.1%)
$27.99 M(-6.5%)
Sep 2018
-
$29.95 M(-2.6%)
Jun 2018
-
$30.75 M(+17.4%)
Mar 2018
-
$26.19 M(+20.4%)
Dec 2017
$82.60 M(+10.2%)
$21.75 M(-1.6%)
Sep 2017
-
$22.11 M(+18.8%)
Jun 2017
-
$18.61 M(-7.5%)
Mar 2017
-
$20.12 M(+17.2%)
Dec 2016
$74.96 M(-14.5%)
$17.17 M(+1.0%)
Sep 2016
-
$17.00 M(+0.5%)
Jun 2016
-
$16.92 M(-29.1%)
Mar 2016
-
$23.87 M(+9.5%)
Dec 2015
$87.70 M(+47.7%)
$21.80 M(-9.7%)
Sep 2015
-
$24.15 M(+17.8%)
Jun 2015
-
$20.50 M(-3.6%)
Mar 2015
-
$21.26 M(+3.2%)
Dec 2014
$59.38 M(+23.6%)
$20.60 M(+38.8%)
Sep 2014
-
$14.85 M(+13.5%)
Jun 2014
-
$13.09 M(+20.7%)
Mar 2014
-
$10.84 M(-35.8%)
Dec 2013
$48.05 M(-17.8%)
$16.90 M(+81.5%)
Sep 2013
-
$9.31 M(-28.1%)
Jun 2013
-
$12.96 M(+46.1%)
Mar 2013
-
$8.87 M(-32.0%)
Dec 2012
$58.42 M(-15.6%)
$13.04 M(-5.4%)
Sep 2012
-
$13.78 M(-4.2%)
Jun 2012
-
$14.39 M(-16.5%)
Mar 2012
-
$17.22 M(+5.9%)
Dec 2011
$69.23 M(-27.7%)
$16.27 M(-9.9%)
Sep 2011
-
$18.05 M(+0.4%)
Jun 2011
-
$17.98 M(+6.2%)
Mar 2011
-
$16.93 M(-34.8%)
Dec 2010
$95.70 M(+8.4%)
$25.97 M(+13.0%)
Sep 2010
-
$22.99 M(+28.1%)
Jun 2010
-
$17.95 M(-37.7%)
Mar 2010
-
$28.80 M(-27.7%)
Dec 2009
$88.33 M
$39.81 M(+87.4%)
Sep 2009
-
$21.25 M(+57.1%)
DateAnnualQuarterly
Jun 2009
-
$13.53 M(-1.6%)
Mar 2009
-
$13.75 M(-43.7%)
Dec 2008
$83.73 M(-19.1%)
$24.44 M(+32.3%)
Sep 2008
-
$18.47 M(+15.1%)
Jun 2008
-
$16.04 M(-35.3%)
Mar 2008
-
$24.78 M(-21.6%)
Dec 2007
$103.52 M(+94.6%)
$31.60 M(-2.2%)
Sep 2007
-
$32.33 M(+53.7%)
Jun 2007
-
$21.03 M(+108.2%)
Mar 2007
-
$10.10 M(-21.3%)
Dec 2006
$53.19 M(+94.6%)
$12.83 M(-29.7%)
Sep 2006
-
$18.25 M(+45.1%)
Jun 2006
-
$12.57 M(+31.8%)
Mar 2006
-
$9.54 M(+27.0%)
Dec 2005
$27.33 M(+23.7%)
$7.51 M(-5.7%)
Sep 2005
-
$7.96 M(+32.9%)
Jun 2005
-
$5.99 M(+2.0%)
Mar 2005
-
$5.87 M(+4.7%)
Dec 2004
$22.09 M(+54.1%)
$5.61 M(+0.7%)
Sep 2004
-
$5.57 M(+5.5%)
Jun 2004
-
$5.27 M(-6.5%)
Mar 2004
-
$5.64 M(+38.1%)
Dec 2003
$14.33 M(-23.4%)
$4.09 M(+12.6%)
Sep 2003
-
$3.63 M(+3.2%)
Jun 2003
-
$3.52 M(+13.6%)
Mar 2003
-
$3.10 M(-10.8%)
Dec 2002
$18.70 M(+15.9%)
$3.47 M(-9.3%)
Sep 2002
-
$3.83 M(-27.1%)
Jun 2002
-
$5.25 M(-14.7%)
Mar 2002
-
$6.16 M(+2.2%)
Dec 2001
$16.14 M(+22.8%)
$6.03 M(+71.2%)
Sep 2001
-
$3.52 M(-1.7%)
Jun 2001
-
$3.58 M(+9.5%)
Mar 2001
-
$3.27 M(-15.3%)
Dec 2000
$13.15 M(+24.0%)
$3.86 M(+40.5%)
Sep 2000
-
$2.75 M(-24.1%)
Jun 2000
-
$3.62 M(+21.6%)
Mar 2000
-
$2.98 M(+24.0%)
Dec 1999
$10.60 M(-14.5%)
$2.40 M(-7.7%)
Sep 1999
-
$2.60 M(-3.7%)
Jun 1999
-
$2.70 M(-10.0%)
Mar 1999
-
$3.00 M(+36.4%)
Dec 1998
$12.40 M(-6.8%)
$2.20 M(-38.9%)
Sep 1998
-
$3.60 M(+9.1%)
Jun 1998
-
$3.30 M(0.0%)
Mar 1998
-
$3.30 M(-2.9%)
Dec 1997
$13.30 M(+29.1%)
$3.40 M(+17.2%)
Sep 1997
-
$2.90 M(-17.1%)
Jun 1997
-
$3.50 M(-2.8%)
Mar 1997
-
$3.60 M(+38.5%)
Dec 1996
$10.30 M(+10.8%)
$2.60 M(-3.7%)
Sep 1996
-
$2.70 M(-10.0%)
Jun 1996
-
$3.00 M(+50.0%)
Mar 1996
-
$2.00 M(-16.7%)
Dec 1995
$9.30 M(+24.0%)
$2.40 M(+9.1%)
Sep 1995
-
$2.20 M(+22.2%)
Jun 1995
-
$1.80 M(-41.9%)
Mar 1995
-
$3.10 M(+47.6%)
Dec 1994
$7.50 M
$2.10 M(+10.5%)
Sep 1994
-
$1.90 M(-5.0%)
Jun 1994
-
$2.00 M(+25.0%)
Mar 1994
-
$1.60 M

FAQ

  • What is BioCryst Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual total expenses year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly total expenses year-on-year change?

What is BioCryst Pharmaceuticals annual total expenses?

The current annual total expenses of BCRX is $435.12 M

What is the all time high annual total expenses for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual total expenses is $435.12 M

What is BioCryst Pharmaceuticals annual total expenses year-on-year change?

Over the past year, BCRX annual total expenses has changed by +$15.86 M (+3.78%)

What is BioCryst Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of BCRX is $109.39 M

What is the all time high quarterly total expenses for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly total expenses is $136.07 M

What is BioCryst Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, BCRX quarterly total expenses has changed by $0.00 (0.00%)